Sarepta Announces PDUFA Extension and Update for the FDA’s Review of SRP-9001
Sarepta Therapeutics announced today that they received an update from the FDA on the Biologics License Application (BLA) for SRP-9001. The PDUFA date reportedly has been extended to June 22, 2023. …Learn More